Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

*Product:*	Aprepitant
*Component 1:*
Active Ingredient:	Aprepitant 80mg
Dosage Form:	Capsule
*Component 2:*
Active Ingredient:	Aprepitant 125mg
Dosage Form:	Capsule
New Zealand Sponsor:	Alchemy Health Limited
Manufacturer:	Pharmathen International SA, Rodopi, Greece

*Product:*	Aprepitant
Active Ingredient:	Aprepitant 40mg
Dosage Form:	Capsule
New Zealand Sponsor:	Alchemy Health Limited
Manufacturer:	Pharmathen International SA, Rodopi, Greece

*Product:*	Aprepitant
Active Ingredient:	Aprepitant 80mg
Dosage Form:	Capsule
New Zealand Sponsor:	Alchemy Health Limited
Manufacturer:	Pharmathen International SA, Rodopi, Greece

*Product:*	Aprepitant
Active Ingredient:	Aprepitant 125mg
Dosage Form:	Capsule
New Zealand Sponsor:	Alchemy Health Limited
Manufacturer:	Pharmathen International SA, Rodopi, Greece

*Product:*	CRESEMBA
Active Ingredient:	Isavuconazonium sulfate 186.3mg equivalent to isavuconazole 100mg
Dosage Form:	Capsule
New Zealand Sponsor:	Pfizer New Zealand Limited
Manufacturer:	SwissCo Services AG, Sisseln, Switzerland

*Product:*	CRESEMBA
Active Ingredient:	Isavuconazonium sulfate 372.6mg equivalent to isavuconazole 200mg
Dosage Form:	Powder for injection
New Zealand Sponsor:	Pfizer New Zealand Limited
Manufacturer:	Baxter Pharmaceutical Solutions LLC, Indiana, United States of America

Dated this 15th day of August 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule